Viemed Healthcare (VMD)
(Delayed Data from NSDQ)
$7.38 USD
-0.10 (-1.34%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $7.38 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Viemed Healthcare, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 13 | 17 | 28 | 31 | 13 |
Receivables | 18 | 15 | 15 | 12 | 12 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5 | 4 | 2 | 2 | 1 |
Other Current Assets | 2 | 4 | 2 | 2 | 2 |
Total Current Assets | 38 | 40 | 47 | 47 | 28 |
Net Property & Equipment | 74 | 68 | 63 | 55 | 55 |
Investments & Advances | 4 | 4 | 2 | 1 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 5 | 3 | 5 | 9 | 0 |
Intangibles | 30 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 1 | 2 | 1 | 1 | 0 |
Total Assets | 155 | 117 | 118 | 113 | 83 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 4 | 3 | 3 | 2 | 5 |
Current Portion Long-Term Debt | 1 | 0 | 1 | 2 | 2 |
Current Portion Capital Leases | 0 | 1 | 0 | 3 | 7 |
Accrued Expenses | 18 | 11 | 9 | 13 | 9 |
Income Taxes Payable | 2 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 6 | 5 | 4 | 3 | 3 |
Total Current Liabilities | 32 | 19 | 18 | 23 | 26 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 6 | 0 | 4 | 6 | 8 |
Non-Current Capital Leases | 0 | 0 | 0 | 1 | 3 |
Other Non-Current Liabilities | 1 | 1 | 1 | 1 | 2 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 41 | 20 | 23 | 31 | 39 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 19 | 15 | 14 | 9 | 3 |
Capital Surplus | 16 | 12 | 8 | 7 | 6 |
Retained Earnings | 80 | 70 | 73 | 66 | 34 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 114 | 97 | 95 | 82 | 44 |
Total Liabilities & Shareholder's Equity | 155 | 117 | 118 | 113 | 83 |
Total Common Equity | 114 | 97 | 95 | 82 | 44 |
Shares Outstanding | 38.50 | 38.00 | 39.60 | 39.00 | 37.90 |
Book Value Per Share | 2.96 | 2.56 | 2.39 | 2.09 | 1.15 |
Fiscal Year End for Viemed Healthcare, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 7 | 13 | 10 | 10 | 24 |
Receivables | 24 | 18 | 18 | 19 | 16 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 4 | 5 | 5 | 4 | 3 |
Other Current Assets | 2 | 2 | 3 | 2 | 3 |
Total Current Assets | 39 | 38 | 36 | 36 | 47 |
Net Property & Equipment | 74 | 74 | 73 | 73 | 68 |
Investments & Advances | 4 | 4 | 4 | 4 | 4 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 5 | 5 | 4 | 4 | 4 |
Intangibles | 30 | 30 | 30 | 30 | 0 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 2 |
Total Assets | 155 | 155 | 149 | 149 | 125 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 6 | 4 | 6 | 6 | 4 |
Current Portion Long-Term Debt | 1 | 1 | 2 | 3 | 0 |
Current Portion Capital Leases | 0 | 0 | 1 | 1 | 0 |
Accrued Expenses | 14 | 18 | 17 | 16 | 13 |
Income Taxes Payable | 3 | 2 | 0 | 0 | 1 |
Other Current Liabilities | 6 | 6 | 6 | 6 | 5 |
Total Current Liabilities | 30 | 32 | 32 | 32 | 23 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 6 | 6 | 8 | 12 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 1 | 1 | 1 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 39 | 41 | 41 | 45 | 25 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 22 | 19 | 19 | 18 | 17 |
Capital Surplus | 14 | 16 | 14 | 13 | 12 |
Retained Earnings | 80 | 80 | 76 | 73 | 71 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 116 | 114 | 109 | 105 | 100 |
Total Liabilities & Shareholder's Equity | 155 | 155 | 149 | 149 | 125 |
Total Common Equity | 116 | 114 | 109 | 105 | 100 |
Shares Outstanding | 38.80 | 38.50 | 38.40 | 38.20 | 38.20 |
Book Value Per Share | 3.00 | 2.96 | 2.83 | 2.74 | 2.62 |